Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 1
1949 3
1950 1
1951 2
1952 1
1953 1
1954 2
1955 4
1956 3
1957 3
1958 4
1959 5
1960 4
1961 1
1962 1
1963 1
1964 3
1969 1
1970 1
1971 1
1973 1
1977 1
1978 2
1979 1
1980 2
1981 4
1982 3
1983 2
1984 2
1985 1
1986 1
1988 2
1989 1
1990 5
1991 3
1992 9
1993 8
1994 3
1995 2
1996 1
1998 1
1999 6
2000 1
2001 2
2002 3
2003 6
2004 1
2005 4
2006 2
2007 6
2008 3
2009 2
2010 6
2011 3
2012 9
2013 6
2014 8
2015 9
2016 9
2017 9
2018 13
2019 17
2020 15
2021 15
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

248 results
Results by year
Filters applied: . Clear all
Page 1
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, Isla D, Tamura M, Zhu T, Robledo KP, Gebski V, Asher R, Behan V, Nicklin JL, Coleman RL, Obermair A. Ramirez PT, et al. Among authors: asher r. N Engl J Med. 2018 Nov 15;379(20):1895-1904. doi: 10.1056/NEJMoa1806395. Epub 2018 Oct 31. N Engl J Med. 2018. PMID: 30380365 Clinical Trial.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Poveda A, Floquet A, Ledermann JA, Asher R, Penson RT, Oza AM, Korach J, Huzarski T, Pignata S, Friedlander M, Baldoni A, Park-Simon TW, Tamura K, Sonke GS, Lisyanskaya A, Kim JH, Filho EA, Milenkova T, Lowe ES, Rowe P, Vergote I, Pujade-Lauraine E; SOLO2/ENGOT-Ov21 investigators. Poveda A, et al. Among authors: asher r. Lancet Oncol. 2021 May;22(5):620-631. doi: 10.1016/S1470-2045(21)00073-5. Epub 2021 Mar 18. Lancet Oncol. 2021. PMID: 33743851 Clinical Trial.
Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial.
Obermair A, Asher R, Pareja R, Frumovitz M, Lopez A, Moretti-Marques R, Rendon G, Ribeiro R, Tsunoda A, Behan V, Buda A, Bernadini MQ, Zhao H, Vieira M, Walker J, Spirtos NM, Yao S, Chetty N, Zhu T, Isla D, Tamura M, Nicklin J, Robledo KP, Gebski V, Coleman RL, Salvo G, Ramirez PT. Obermair A, et al. Among authors: asher r. Am J Obstet Gynecol. 2020 Mar;222(3):249.e1-249.e10. doi: 10.1016/j.ajog.2019.09.036. Epub 2019 Oct 3. Am J Obstet Gynecol. 2020. PMID: 31586602 Free PMC article. Clinical Trial.
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.
Frumovitz M, Obermair A, Coleman RL, Pareja R, Lopez A, Ribero R, Isla D, Rendon G, Bernardini MQ, Buda A, Moretti-Marquez R, Zevallos A, Vieira MA, Zhu T, Land RP, Nicklin J, Asher R, Robledo KP, Gebski V, Ramirez PT. Frumovitz M, et al. Among authors: asher r. Lancet Oncol. 2020 Jun;21(6):851-860. doi: 10.1016/S1470-2045(20)30081-4. Lancet Oncol. 2020. PMID: 32502445 Clinical Trial.
Phylogenetic Signal and Bias in Paleontology.
Asher RJ, Smith MR. Asher RJ, et al. Syst Biol. 2021 Sep 1:syab072. doi: 10.1093/sysbio/syab072. Online ahead of print. Syst Biol. 2021. PMID: 34469583
Recurrent time-to-event models with ordinal outcomes.
Gebski V, Byth K, Asher R, Marschner I. Gebski V, et al. Among authors: asher r. Pharm Stat. 2021 Jan;20(1):77-92. doi: 10.1002/pst.2057. Epub 2020 Oct 2. Pharm Stat. 2021. PMID: 33006268
Open data and digital morphology.
Davies TG, Rahman IA, Lautenschlager S, Cunningham JA, Asher RJ, Barrett PM, Bates KT, Bengtson S, Benson RB, Boyer DM, Braga J, Bright JA, Claessens LP, Cox PG, Dong XP, Evans AR, Falkingham PL, Friedman M, Garwood RJ, Goswami A, Hutchinson JR, Jeffery NS, Johanson Z, Lebrun R, Martínez-Pérez C, Marugán-Lobón J, O'Higgins PM, Metscher B, Orliac M, Rowe TB, Rücklin M, Sánchez-Villagra MR, Shubin NH, Smith SY, Starck JM, Stringer C, Summers AP, Sutton MD, Walsh SA, Weisbecker V, Witmer LM, Wroe S, Yin Z, Rayfield EJ, Donoghue PC. Davies TG, et al. Among authors: asher rj. Proc Biol Sci. 2017 Apr 12;284(1852):20170194. doi: 10.1098/rspb.2017.0194. Epub 2017 Apr 12. Proc Biol Sci. 2017. PMID: 28404779 Free PMC article. Review.
Myxoedema.
ASHER RA. ASHER RA. Med Illus. 1951 Aug;5(8):388-94. Med Illus. 1951. PMID: 14862770 No abstract available.
Cholinergic medication for antipsychotic-induced tardive dyskinesia.
Tammenmaa-Aho I, Asher R, Soares-Weiser K, Bergman H. Tammenmaa-Aho I, et al. Among authors: asher r. Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000207. doi: 10.1002/14651858.CD000207.pub2. Cochrane Database Syst Rev. 2018. PMID: 29553158 Free PMC article. Review.
Making sense.
ASHER R. ASHER R. Lancet. 1959 Sep 19;2(7099):359-65. doi: 10.1016/s0140-6736(59)91633-2. Lancet. 1959. PMID: 13794725 No abstract available.
248 results